CONTACT INFORMATIONBIOGRAPHYCREDENTIALSPUBLICATIONSSally A. Quataert, Ph.D.Contact InformationPhone NumbersOffice: (585) 273-2454LocationsUniversity of Rochester Medical CenterSchool of Medicine and Dentistry601 Elmwood Ave, Box 609Rochester, NY 14642Faculty AppointmentsResearch Associate Professor - Department of Microbiology and Immunology , Center for Vaccine Biology and Immunology (SMD) BiographyProfessional BackgroundDr. Sally A. Quataert, Director of the Human Immunology Center (HIC) Core Laboratory, is an internationally recognized expert in bioanalytical method development and standardization. She received her Ph.D. in Microbiology from the State University of New York at Buffalo and has over 25 years in the pharmaceutical and medical device fields. Under her leadership and scientific direction, her laboratory at Wyeth Vaccines (formerly Lederle-Praxis Biologicals) established W.H.O. recognized methods for evaluating serological correlates for immune protection with polysaccharide conjugate vaccines for Neisseria meningitis, Haemophilus influenzae, and Streptococcus pneumoniae. Dr. Quataert has extensive experience in conducting inter-laboratory studies and method validation in support of pre-clinical and clinical testing. She was responsible for all aspects of laboratory regulatory compliance and quality systems management in the performance of clinical trial evaluations for vaccine development at Wyeth. Prior to joining Wyeth, Dr. Quataert worked for Electro-Nucleonics, Inc. and Corning Glass Works in the development of immunodiagnostic tests and monoclonal antibody reagents for the biomedical field. Early in her career, Dr. Quataert's interest focused in developing methods for the evaluation of human immune responses in the field of tumor immunology. Her goals for the HIC Core lab are to reduce to practise the highest quality innovative bioanalytical techniques for evaluation of human immune responses and to assist biomedical researchers in the acquisition and execution of these techniques.ResearchThe mission of the Human Immunology Center is to provide expertise for applying new cutting edge immunological techniques from basic animal research through development and standardization to human research. Research in the HIC core laboratory supports exploratory clinical research programs by establishing measures for immune status and response across multiple disciplines and programs. Standard procedures using 18-color multichromatic flow cytometry for cell analysis and 15-color cell sorting, Elispot, fluorispot and lysispot are available for application to clinical trials including lymphoma, autoimmunity, and infectious disease. New techniques provide insight into T, B, dendritic and antigen presenting cell regulation, activation and interactions. Standardized reagent panels for human cell differentiation and activation markers provide the consistency needed to allow interpretation of complex data from analysis of human immune compartmentsCredentialsEducation1974BA | Elmira CollegeBiology and Chemistry1983MA, Ph.D. | St Univ at BuffaloMicrobiology and ImmunologyPost-doctoral Training & Residency1982 - 1984University of Connecticut Medical Center PDF ImmunologyPublicationsJournal Articles7/2/2018Roumanes D, Falsey AR, Quataert S, Secor-Socha S, Lee FE, Yang H, Bandyopadhyay S, Holden-Wiltse J, Topham DJ, Walsh EE. "T-Cell Responses in Adults During Natural Respiratory Syncytial Virus Infection." The Journal of infectious diseases.. 2018 Jul 2; 218(3):418-428. 3/12/2018Jennings-Gee J, Quataert S, Ganguly T, D'Agostino R, Deora R, Dubey P. "The adjuvant Bordetella Colonization Factor A attenuates alum-induced Th2 responses and enhances clearance from mouse lungs." Infection and immunity.. 2018 Mar 12; Epub 2018 Mar 12. 1/2018Tati S, Fisk JC, Abdullah J, Karacosta L, Chrisikos T, Philbin P, Morey S, Ghazal D, Zalzala F, Jessee J, Quataert S, Koury S, Moreno D, Eng JY, Glinsky VV, Glinskii OV, Sesay M, Gebhard AW, Birthare K, Olson JR, Rittenhouse-Olson K. "Corrigendum to "Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis" [Neoplasia 19.9 (2017) 716-733]." Neoplasia : an international journal for oncology research.. 2018 Jan 0; 20(1):118. VIEW ALL PUBLICATIONS